433 related articles for article (PubMed ID: 21073280)
1. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Leng RX; Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs.
Kunz S; Wolk K; Witte E; Witte K; Doecke WD; Volk HD; Sterry W; Asadullah K; Sabat R
Exp Dermatol; 2006 Dec; 15(12):991-1004. PubMed ID: 17083366
[TBL] [Abstract][Full Text] [Related]
3. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Xin N; Namaka MP; Dou C; Zhang Y
Int Immunopharmacol; 2015 Oct; 28(2):1076-83. PubMed ID: 26311525
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
Xie Q; Huang C; Li J
Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
7. The novel interleukin-1 cytokine family members in inflammatory diseases.
Hahn M; Frey S; Hueber AJ
Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540
[TBL] [Abstract][Full Text] [Related]
8. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
[TBL] [Abstract][Full Text] [Related]
9. IL-20 receptor cytokines in autoimmune diseases.
Chen J; Caspi RR; Chong WP
J Leukoc Biol; 2018 Nov; 104(5):953-959. PubMed ID: 30260500
[TBL] [Abstract][Full Text] [Related]
10. IL-19 as a potential therapeutic in autoimmune and inflammatory diseases.
Azuma YT; Nakajima H; Takeuchi T
Curr Pharm Des; 2011 Nov; 17(34):3776-80. PubMed ID: 22103848
[TBL] [Abstract][Full Text] [Related]
11. IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential.
Boutet MA; Nerviani A; Pitzalis C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871134
[TBL] [Abstract][Full Text] [Related]
12. IL-33: a promising therapeutic target for rheumatoid arthritis?
Yuan FL; Li X; Lu WG; Li CW; Xu RS; Dong J
Expert Opin Ther Targets; 2011 May; 15(5):529-34. PubMed ID: 21446881
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of anti-interleukin-20 monoclonal antibody.
Hsu YH; Chang MS
Cell Transplant; 2014; 23(4-5):631-9. PubMed ID: 24816455
[TBL] [Abstract][Full Text] [Related]
14. IL-38: A New Player in Inflammatory Autoimmune Disorders.
Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22: a likely target for treatment of autoimmune diseases.
Yang X; Zheng SG
Autoimmun Rev; 2014 Jun; 13(6):615-20. PubMed ID: 24418299
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines.
Logsdon NJ; Deshpande A; Harris BD; Rajashankar KR; Walter MR
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12704-9. PubMed ID: 22802649
[TBL] [Abstract][Full Text] [Related]
17. The enigmatic role of IL-38 in inflammatory diseases.
Garraud T; Harel M; Boutet MA; Le Goff B; Blanchard F
Cytokine Growth Factor Rev; 2018 Feb; 39():26-35. PubMed ID: 29366546
[TBL] [Abstract][Full Text] [Related]
18. The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2.
Wegenka UM; Dikopoulos N; Reimann J; Adler G; Wahl C
J Hepatol; 2007 Feb; 46(2):257-65. PubMed ID: 17069926
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
20. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
Rømer J; Hasselager E; Nørby PL; Steiniche T; Thorn Clausen J; Kragballe K
J Invest Dermatol; 2003 Dec; 121(6):1306-11. PubMed ID: 14675174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
